Latest Breaking News On - Brianm strem - Page 1 : comparemela.com

Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease

Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesBrianm stremUniversity of californiaKiora pharmaceuticalsKiora pharmaceuticals incAssociation of researchCalifornia newsfile corpOpen innovationMelissa toscaInvestigational new drugInitiate phasePrivate securities litigation reform actAnnual reportCurrent assetsRelease assetsCurrent liabilities

Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases

Kiora Pharmaceuticals, Inc. today announced its 2023 financial results and provided an update on its retinal disease development pipeline. The Company s major initiatives planned for 2024 are to.

Brianm stremCalifornia newsfile corpKiora pharmaceuticals incKiora pharmaceuticalsOpen innovationMelissa toscaUpcoming milestonesOrphan drug designationsPrivate securities litigation reform actAnnual report

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Brianm stremDennis riedlKiora pharmaceuticals incCalifornia newsfile corpKiora pharmaceuticalsOpen innovationMelissa toscaUpcoming milestonesOrphan drug designationsPrivate securities litigation reform actAnnual report

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesBrianm stremStefan klotterKiora pharmaceuticalsCompany phaseCalifornia newsfile corpKiora pharmaceuticals incMaxim groupExchange commissionNantahala capital managementRosalind advisorsStonepine capital managementVelan capitalOpen innovationChief executiveSecurities act

Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million

Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBrianm stremExchange commissionMaxim groupKiora pharmaceuticals incCompany phaseCalifornia newsfile corpKiora pharmaceuticalsNantahala capital managementRosalind advisorsStonepine capital managementVelan capitalTha open innovationChief executiveSecurities actPrivate securities litigation reform act